Daniel Gibbs (Emeritus of Oregon Health and Science University)
Dispatches from the Land of Alzheimer's
19,99 €
inkl. MwSt.
Sofort lieferbar
10 °P sammeln
Daniel Gibbs (Emeritus of Oregon Health and Science University)
Dispatches from the Land of Alzheimer's
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Daniel Gibbs is a retired neurologist who was diagnosed with Alzheimer's Disease in 2015. This book presents a hopeful and humane collection of essays written over the past two years about his own experience of navigating the disease and advances in research.
Andere Kunden interessierten sich auch für
- Alzheimer's SocietyThe Brain Health Puzzle Book10,99 €
- Nick Brindle (Leeds and York Partnership NHS Foundation Trust)A Clinician's Brief Guide to Dementia and the Law26,99 €
- Anthea InnesDementia31,99 €
- Dr. Lisa MosconiThe XX Brain9,99 €
- Dr Dale BredesenThe End of Alzheimer's Programme14,99 €
- Chris WilliamsOvercoming Depression and Low Mood in Older Adults28,99 €
- Catherine DoyleThe Storm Keeper's Island8,49 €
-
-
-
Daniel Gibbs is a retired neurologist who was diagnosed with Alzheimer's Disease in 2015. This book presents a hopeful and humane collection of essays written over the past two years about his own experience of navigating the disease and advances in research.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 228
- Erscheinungstermin: 22. Februar 2024
- Englisch
- Abmessung: 195mm x 126mm x 12mm
- Gewicht: 236g
- ISBN-13: 9781009430050
- ISBN-10: 100943005X
- Artikelnr.: 68504694
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
- Verlag: Cambridge University Press
- Seitenzahl: 228
- Erscheinungstermin: 22. Februar 2024
- Englisch
- Abmessung: 195mm x 126mm x 12mm
- Gewicht: 236g
- ISBN-13: 9781009430050
- ISBN-10: 100943005X
- Artikelnr.: 68504694
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
Daniel Gibbs is a retired general neurologist with mild Alzheimer's dementia. He has written previously about his experiences as seen from two points of view, doctor and patient, in A Tattoo on my Brain: A Neurologist's Personal Battle against Alzheimer's Disease, Cambridge University Press, 2021 and 2023 (revised edition).
1. Physician heal thyself
2. Evaluating new advances in Alzheimer's research - separating hype from fact
3. Alzheimer's dementia or Alzheimer's disease - what's the difference and why should we care?
4. The first patient with Alzheimer's disease
5. Kidnapped in Kinshasa
6. Smell, disgust and Alzheimer's
7. Apolipoprotein-4 (APOE-4): bad for the brain and bad for the heart
8. Lost in the fog of Alzheimer's
9. My father's 'stuff'
10. Face blindness during a pandemic
11. Biomarkers for Alzheimer's disease
12. Olfactory impairment in Covid-19 and Alzheimer's
13. Alzheimer's disease and work
14. Crossword controversies
15. Can loneliness increase risk for dementia?
16. Excessive laxative use and dementia
17. Dog dementia (canine cognitive dysfunction)
18. The possible role of brain inflammation in Alzheimer's disease may be more significant in APOE-4 carriers
19. Surprisingly good news about the acetylcholinesterase inhibitors (donepezil, rivastigmine, and galantamine)
20. More about the importance of exercise
21. Rolling on the river
22. The MIND Diet revisited
23. My photographs, then and now
24. Does cataract surgery really decrease the risk of dementia?
25. Hearing loss, aphasia and dementia
26. To sleep, perchance to dream
27. The amyloid hypothesis is not dead, but it may be gasping for breath
28. Could Lecanemab offer a ray of hope?
29. A fatal case of multiple brain hemorrhages associated with Lecanemab
30. Cerebral amyloid angiopathy (CAA) - should it be a contraindication for drugs like Lecanemab?
31. Hitting the sweet spot in the spectrum of Alzheimer's disease for future trials of anti-amyloid medications
32. Disappointing results of two human trials of monoclonal antibodies in Parkinson's disease
33. Repurposing old drugs for Alzheimer's treatment
34. Writing while impaired
35. Spreading the word
36. Saying goodbye to Lizzy G
37. Amyloid and tau PET scans of my brain
38. Running on a field of dreams
39. Living in the moment.
2. Evaluating new advances in Alzheimer's research - separating hype from fact
3. Alzheimer's dementia or Alzheimer's disease - what's the difference and why should we care?
4. The first patient with Alzheimer's disease
5. Kidnapped in Kinshasa
6. Smell, disgust and Alzheimer's
7. Apolipoprotein-4 (APOE-4): bad for the brain and bad for the heart
8. Lost in the fog of Alzheimer's
9. My father's 'stuff'
10. Face blindness during a pandemic
11. Biomarkers for Alzheimer's disease
12. Olfactory impairment in Covid-19 and Alzheimer's
13. Alzheimer's disease and work
14. Crossword controversies
15. Can loneliness increase risk for dementia?
16. Excessive laxative use and dementia
17. Dog dementia (canine cognitive dysfunction)
18. The possible role of brain inflammation in Alzheimer's disease may be more significant in APOE-4 carriers
19. Surprisingly good news about the acetylcholinesterase inhibitors (donepezil, rivastigmine, and galantamine)
20. More about the importance of exercise
21. Rolling on the river
22. The MIND Diet revisited
23. My photographs, then and now
24. Does cataract surgery really decrease the risk of dementia?
25. Hearing loss, aphasia and dementia
26. To sleep, perchance to dream
27. The amyloid hypothesis is not dead, but it may be gasping for breath
28. Could Lecanemab offer a ray of hope?
29. A fatal case of multiple brain hemorrhages associated with Lecanemab
30. Cerebral amyloid angiopathy (CAA) - should it be a contraindication for drugs like Lecanemab?
31. Hitting the sweet spot in the spectrum of Alzheimer's disease for future trials of anti-amyloid medications
32. Disappointing results of two human trials of monoclonal antibodies in Parkinson's disease
33. Repurposing old drugs for Alzheimer's treatment
34. Writing while impaired
35. Spreading the word
36. Saying goodbye to Lizzy G
37. Amyloid and tau PET scans of my brain
38. Running on a field of dreams
39. Living in the moment.
1. Physician heal thyself
2. Evaluating new advances in Alzheimer's research - separating hype from fact
3. Alzheimer's dementia or Alzheimer's disease - what's the difference and why should we care?
4. The first patient with Alzheimer's disease
5. Kidnapped in Kinshasa
6. Smell, disgust and Alzheimer's
7. Apolipoprotein-4 (APOE-4): bad for the brain and bad for the heart
8. Lost in the fog of Alzheimer's
9. My father's 'stuff'
10. Face blindness during a pandemic
11. Biomarkers for Alzheimer's disease
12. Olfactory impairment in Covid-19 and Alzheimer's
13. Alzheimer's disease and work
14. Crossword controversies
15. Can loneliness increase risk for dementia?
16. Excessive laxative use and dementia
17. Dog dementia (canine cognitive dysfunction)
18. The possible role of brain inflammation in Alzheimer's disease may be more significant in APOE-4 carriers
19. Surprisingly good news about the acetylcholinesterase inhibitors (donepezil, rivastigmine, and galantamine)
20. More about the importance of exercise
21. Rolling on the river
22. The MIND Diet revisited
23. My photographs, then and now
24. Does cataract surgery really decrease the risk of dementia?
25. Hearing loss, aphasia and dementia
26. To sleep, perchance to dream
27. The amyloid hypothesis is not dead, but it may be gasping for breath
28. Could Lecanemab offer a ray of hope?
29. A fatal case of multiple brain hemorrhages associated with Lecanemab
30. Cerebral amyloid angiopathy (CAA) - should it be a contraindication for drugs like Lecanemab?
31. Hitting the sweet spot in the spectrum of Alzheimer's disease for future trials of anti-amyloid medications
32. Disappointing results of two human trials of monoclonal antibodies in Parkinson's disease
33. Repurposing old drugs for Alzheimer's treatment
34. Writing while impaired
35. Spreading the word
36. Saying goodbye to Lizzy G
37. Amyloid and tau PET scans of my brain
38. Running on a field of dreams
39. Living in the moment.
2. Evaluating new advances in Alzheimer's research - separating hype from fact
3. Alzheimer's dementia or Alzheimer's disease - what's the difference and why should we care?
4. The first patient with Alzheimer's disease
5. Kidnapped in Kinshasa
6. Smell, disgust and Alzheimer's
7. Apolipoprotein-4 (APOE-4): bad for the brain and bad for the heart
8. Lost in the fog of Alzheimer's
9. My father's 'stuff'
10. Face blindness during a pandemic
11. Biomarkers for Alzheimer's disease
12. Olfactory impairment in Covid-19 and Alzheimer's
13. Alzheimer's disease and work
14. Crossword controversies
15. Can loneliness increase risk for dementia?
16. Excessive laxative use and dementia
17. Dog dementia (canine cognitive dysfunction)
18. The possible role of brain inflammation in Alzheimer's disease may be more significant in APOE-4 carriers
19. Surprisingly good news about the acetylcholinesterase inhibitors (donepezil, rivastigmine, and galantamine)
20. More about the importance of exercise
21. Rolling on the river
22. The MIND Diet revisited
23. My photographs, then and now
24. Does cataract surgery really decrease the risk of dementia?
25. Hearing loss, aphasia and dementia
26. To sleep, perchance to dream
27. The amyloid hypothesis is not dead, but it may be gasping for breath
28. Could Lecanemab offer a ray of hope?
29. A fatal case of multiple brain hemorrhages associated with Lecanemab
30. Cerebral amyloid angiopathy (CAA) - should it be a contraindication for drugs like Lecanemab?
31. Hitting the sweet spot in the spectrum of Alzheimer's disease for future trials of anti-amyloid medications
32. Disappointing results of two human trials of monoclonal antibodies in Parkinson's disease
33. Repurposing old drugs for Alzheimer's treatment
34. Writing while impaired
35. Spreading the word
36. Saying goodbye to Lizzy G
37. Amyloid and tau PET scans of my brain
38. Running on a field of dreams
39. Living in the moment.